Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company plc monthly Stock Chart
Perrigo Company plc
IndexS&P 500 P/E26.07 EPS (ttm)1.75 Insider Own0.20% Shs Outstand136.40M Perf Week-3.71%
Market Cap6.14B Forward P/E10.62 EPS next Y4.29 Insider Trans-0.65% Shs Float135.45M Perf Month1.40%
Income240.20M PEG2.61 EPS next Q0.85 Inst Own85.60% Short Float2.51% Perf Quarter-19.48%
Sales5.07B P/S1.21 EPS this Y13.00% Inst Trans0.16% Short Ratio4.13 Perf Half Y-12.77%
Book/sh43.33 P/B1.05 EPS next Y5.76% ROA2.10% Target Price57.88 Perf Year-15.50%
Cash/sh10.86 P/C4.20 EPS next 5Y10.00% ROE4.10% 52W Range40.01 - 63.86 Perf YTD-11.69%
Dividend0.90 P/FCF14.04 EPS past 5Y3.20% ROI2.00% 52W High-28.56% Beta1.21
Dividend %1.97% Quick Ratio1.50 Sales past 5Y1.00% Gross Margin35.70% 52W Low14.02% ATR1.14
Employees11200 Current Ratio2.00 Sales Q/Q6.10% Oper. Margin6.10% RSI (14)43.94 Volatility2.39% 2.14%
OptionableYes Debt/Eq0.70 EPS Q/Q568.50% Profit Margin4.70% Rel Volume0.51 Prev Close45.48
ShortableYes LT Debt/Eq0.60 EarningsNov 04 BMO Payout49.30% Avg Volume823.39K Price45.62
Recom2.50 SMA20-0.14% SMA50-6.16% SMA200-12.92% Volume416,746 Change0.31%
Apr-17-20Downgrade Argus Buy → Hold
Mar-24-20Upgrade JP Morgan Neutral → Overweight $57
Mar-20-20Upgrade SVB Leerink Mkt Perform → Outperform $54 → $52
Mar-18-20Upgrade RBC Capital Mkts Sector Perform → Outperform $58
Oct-11-19Upgrade Argus Hold → Buy
Mar-20-19Initiated SunTrust Hold
Nov-13-18Downgrade Berenberg Buy → Hold
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Oct-22-20 10:37AM  
Oct-21-20 12:05PM  
Oct-15-20 09:20AM  
Oct-14-20 08:15AM  
Oct-06-20 01:34PM  
Sep-17-20 07:41AM  
Sep-15-20 01:11PM  
Sep-14-20 03:48PM  
Sep-08-20 10:29AM  
Sep-04-20 11:31AM  
Sep-03-20 07:05AM  
Aug-25-20 09:52AM  
Aug-22-20 09:27AM  
Aug-11-20 09:29AM  
Aug-05-20 12:37PM  
Aug-04-20 12:02PM  
Aug-02-20 10:15AM  
Jul-31-20 11:30AM  
Jul-29-20 02:00PM  
Jul-21-20 01:21PM  
Jul-15-20 08:32AM  
Jul-12-20 08:15PM  
Jun-29-20 07:00AM  
Jun-21-20 03:32PM  
Jun-19-20 02:03PM  
Jun-18-20 06:56PM  
Jun-17-20 01:38PM  
Jun-16-20 04:11PM  
Jun-08-20 02:45AM  
Jun-02-20 12:43PM  
May-30-20 11:31AM  
May-29-20 10:07AM  
May-24-20 11:44AM  
May-16-20 12:51PM  
May-08-20 02:25PM  
May-05-20 04:21PM  
May-04-20 09:45AM  
Apr-30-20 11:16AM  
Apr-29-20 11:09AM  
Apr-27-20 11:01AM  
Apr-24-20 09:05AM  
Apr-23-20 12:32PM  
Apr-22-20 04:18PM  
Apr-21-20 10:17AM  
Apr-16-20 08:03AM  
Apr-15-20 09:55AM  
Apr-09-20 08:27AM  
Apr-08-20 10:41AM  
Apr-07-20 05:14PM  
Apr-06-20 08:30AM  
Apr-02-20 08:30AM  
Mar-28-20 11:30AM  
Mar-22-20 04:46PM  
Mar-17-20 10:10PM  
Mar-13-20 11:32AM  
Feb-27-20 04:42PM  
Feb-26-20 01:12PM  
Feb-25-20 04:27PM  
Feb-24-20 06:57PM  
Feb-23-20 09:42AM  
Feb-20-20 12:31PM  
Feb-18-20 10:17AM  
Feb-17-20 08:46AM  
Feb-13-20 08:30AM  
Feb-07-20 08:10AM  
Feb-06-20 10:11AM  
Feb-05-20 11:40AM  
Feb-03-20 04:10PM  
Jan-31-20 10:56AM  
Jan-29-20 12:10PM  
Jan-28-20 11:18AM  
Jan-20-20 11:40AM  
Jan-15-20 09:36AM  
Jan-14-20 11:25AM  
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid, 24HR, Good Sense, Zephrex D, ScarAway, Plackers, and Rembrandt. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands and consumer focused products through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Willis RobertEVP & CHROAug 14Option Exercise53.4058131,0252,358Aug 17 12:32 PM
Andersen SvendEVP & President CHCIAug 11Buy53.012,828149,91010,028Aug 11 10:58 AM
Janish Ronald CraigEVP, Global Op. & Supply ChainJun 29Option Exercise54.5682745,1219,429Jul 01 02:00 PM
Farrington ThomasEVP and CIOJun 29Option Exercise54.561,39876,27514,803Jul 01 01:58 PM
Kochan SharonEVP, GM InternationalJun 29Option Exercise54.562,285124,67031,307Jul 01 01:59 PM
Quinn GrainneEVP, Chief Medical OfficerJun 29Option Exercise54.5626214,2954,796Jul 01 01:59 PM
Willis RobertEVP & CHROJun 29Option Exercise54.5627014,7311,918Jul 01 01:58 PM
Needham JeffreyEVP, President CHC AmericasJun 29Option Exercise54.562,322126,68832,149Jul 01 01:57 PM
KINGMA TODD WExecutive VP, General CounselJun 29Option Exercise54.562,987162,97140,698Jul 01 01:56 PM
Willis RobertEVP & CHROJun 05Option Exercise55.6160633,7001,964Jun 09 10:16 AM
O'Connor DonalDirectorMay 15Option Exercise52.766,054319,40913,343May 19 08:41 PM
CLASSON ROLF ADirectorMay 15Option Exercise52.767,568399,28812,366May 19 08:41 PM
Samuels Theodore R. IIDirectorMay 15Option Exercise52.766,054319,40914,290May 19 08:42 PM
Mann Erica LDirectorMay 15Option Exercise52.766,054319,4096,054May 19 08:40 PM
Alford Bradley ADirectorMay 15Option Exercise52.766,054319,40910,866May 19 08:40 PM
KINDLER JEFFREY BDirectorMay 15Option Exercise52.766,054319,40910,863May 19 08:39 PM
Karaboutis AdrianaDirectorMay 15Option Exercise52.766,054319,40910,335May 19 08:40 PM
Parker Geoffrey M.DirectorMay 15Option Exercise52.766,054319,40911,347May 19 08:39 PM
Farrington ThomasEVP and CIOMay 07Sale52.132,000104,25413,405May 11 05:05 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainMay 07Sale51.902,595134,6718,602May 11 04:36 PM
SILCOCK RAYMONDEVP, Chief Financial OfficerApr 03Option Exercise44.363,964175,8433,964Apr 07 03:43 PM
Samuels Theodore R. IIDirectorMar 13Buy42.502,00085,00013,618Mar 17 07:04 PM
Needham JeffreyEVP, President CHC AmericasMar 06Option Exercise53.172,960157,38326,718Mar 10 08:58 PM
Andersen SvendEVP & President CHCIMar 06Option Exercise53.172,960157,3836,949Mar 10 08:58 PM
Willis RobertEVP & CHROMar 06Option Exercise53.1755029,244802Mar 10 08:57 PM
Farrington ThomasEVP and CIOMar 06Option Exercise53.171,47078,16011,558Mar 10 08:57 PM
Dillard James E IIIEVP, Chief Scientific OfficerMar 06Option Exercise53.172,326123,6735,282Mar 10 08:56 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainMar 06Option Exercise53.171,79795,5467,803Mar 10 08:56 PM
KESSLER MURRAY SCEOMar 06Option Exercise53.1716,385871,19032,068Mar 10 08:56 PM
Kochan SharonEVP, GM InternationalMar 06Option Exercise53.172,062109,63721,555Mar 10 08:55 PM
KINGMA TODD WExecutive VP, General CounselMar 06Option Exercise53.172,960157,38332,944Mar 10 08:55 PM
Quinn GrainneEVP, Chief Medical OfficerMar 06Option Exercise53.171,22765,2404,274Mar 10 08:51 PM
Dillard James E IIIEVP, Chief Scientific OfficerFeb 07Option Exercise59.914,298257,4934,298Feb 11 08:37 AM
Needham JeffreyEVP, President CHC AmericasDec 31Option Exercise51.666,169318,69125,653Jan 03 03:47 PM
KINGMA TODD WExecutive VP, General CounselDec 20Sale54.912,300126,29329,984Dec 23 01:31 PM
Quinn GrainneEVP, Chief Medical OfficerNov 11Sale49.082,050100,6143,047Nov 13 01:33 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainNov 08Sale49.902,424120,9676,006Nov 12 11:43 AM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.